New guidance for cancer pain and opioid use disorder or opio
In this qualitative study, the use of buprenorphine/naloxone for opioid use disorder was deemed appropriate, but its use for opioid misuse was less clear. Participants considered methadone an important tool for treating opioid use disorder and cancer-related pain, but policy and safety concerns exist. This study provides consensus-based guidance for clinicians and highlights research and policy gaps that warrant urgent attention to meet the needs of people with cancer-related pain and opioid misuse/use disorder.

Source: https://jamanetwork.com/journals/jamaoncology/fullarticle/2793858?
Like
Comment
Share